Vyant Bio Inc
(VYNT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VYNT | AZN | AMGN | GILD | BMY |
| Company | Vyant Bio Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.1800 | 191.80 | 380.70 | 151.85 | 61.37 |
| High | 0.2000 | 192.76 | 384.62 | 153.00 | 61.63 |
| Low | 0.1750 | 187.06 | 372.34 | 150.18 | 60.36 |
| Latest | 0.1940 | 188.18 | 375.88 | 151.70 | 60.74 |
| Change | +0.0140 | -4.85 | -8.44 | -0.80 | -1.25 |
| % Change | +7.78% | -2.51% | -2.20% | -0.52% | -2.02% |
| Volume | 19,100 | 2,708,809 | 1,772,062 | 5,614,040 | 9,953,864 |
| 20-Day Average Volume | 32,920 | 4,806,895 | 3,059,929 | 8,091,689 | 13,453,535 |
| Previous Close | 0.1800 | 193.03 | 384.32 | 152.50 | 61.99 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.1727 | 187.02 | 345.63 | 136.03 | 56.22 |
| 20-Day Raw Stochastic | 85.33% | 57.11% | 88.05% | 95.04% | 80.54% |
| 20-Day Relative Strength | 61.39 | 52.03 | 67.10 | 74.95 | 66.73 |
| Weighted Alpha | -57.87 | +31.07 | +37.87 | +54.74 | +23.37 |
| Today's Opinion | 8% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 32% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 64% Sell | 100% Buy | 96% Buy | 40% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +12.46% since 12/21/23 | -0.67% since 02/02/26 | +9.47% since 02/02/26 | +6.00% since 02/02/26 | +8.06% since 02/02/26 |
| Low | 0.1670 on 12/26/23 | 183.63 on 02/03/26 | 338.59 on 02/03/26 | 142.03 on 02/03/26 | 55.49 on 02/03/26 |
| High | 0.2000 on 12/29/23 | 193.97 on 02/06/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 1-Month | |||||
| %Chg | +9.30% since 11/29/23 | -1.13% since 01/09/26 | +15.70% since 01/09/26 | +25.08% since 01/09/26 | +8.12% since 01/09/26 |
| Low | 0.1591 on 12/11/23 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.63 on 01/12/26 | 53.54 on 01/21/26 |
| High | 0.2000 on 12/29/23 | 193.97 on 02/06/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 3-Month | |||||
| %Chg | +14.12% since 09/29/23 | +10.64% since 11/07/25 | +17.84% since 11/07/25 | +27.46% since 11/07/25 | +29.35% since 11/07/25 |
| Low | 0.1500 on 10/09/23 | 171.69 on 11/10/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 0.2100 on 11/02/23 | 193.97 on 02/06/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 6-Month | |||||
| %Chg | -3.00% since 06/29/23 | +27.23% since 08/08/25 | +30.91% since 08/08/25 | +26.85% since 08/08/25 | +31.44% since 08/08/25 |
| Low | 0.1410 on 09/25/23 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 0.2900 on 08/03/23 | 193.97 on 02/06/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,228 | 299,371,776 | 206,949,024 | 189,203,696 | 126,196,336 |
| Shares Outstanding, K | 6,329 | 1,550,908 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 670,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 48,300,000,000 |
| Annual Net Income | -22,690,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -8,948,000,000 |
| Last Quarter Sales | 120,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 12,222,000,000 |
| Last Quarter Net Income | -1,630,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 2,201,000,000 |
| 60-Month Beta | 1.68 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 1.19 on 11/06/25 | 5.29 on 02/03/26 | 2.47 on 10/30/25 | 1.26 on 02/05/26 |
| Latest Earnings Date | 01/01/70 | 02/10/26 | 05/07/26 | 02/10/26 | 04/23/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.48 | 16.83 | 18.24 | 9.68 |